Glucose Com Cloreto De Sodio Basi

Glucose Com Cloreto De Sodio Basi is a sterile aqueous solution for injection that combines sodium chloride and glucose as its active ingredients. The product is supplied in a ready‑to‑use liquid form intended for intravenous administration. It is manufactured for the European market and conforms to EU pharmaceutical standards, providing an isotonic carrier that can be used in various clinical settings where fluid and electrolyte replacement is required.

Glucose Com Cloreto De Sodio Basi is employed in clinical practice primarily as an intravenous fluid to support patients who need volume expansion and electrolyte balance.

- Replenishment of extracellular fluid volume in dehydration or blood loss. - Provision of sodium and chloride ions to maintain plasma osmolality. - Supply of glucose as an immediate energy substrate during peri‑operative care. - Dilution and compatible administration of other intravenous medications. - Support for patients receiving parenteral nutrition or undergoing dialysis. - Temporary correction of mild hyponatremia when rapid sodium increase is not required.

The safety profile of Glucose Com Cloreto De Sodio Basi reflects the typical reactions observed with isotonic sodium chloride and glucose solutions administered intravenously.

Common: - Mild pain or irritation at the injection site. - Transient increase in blood glucose levels. - Slight elevation of serum sodium concentration. - Temporary feeling of warmth or flushing during infusion. - Minor electrolyte shifts that resolve without intervention. - Slight increase in urine output during and shortly after infusion.

Serious: - Hypernatremia resulting from excessive sodium load. - Hyperglycemia in patients with impaired glucose tolerance. - Allergic or anaphylactic reaction to the solution components. - Fluid overload in patients with compromised cardiac function. - Metabolic acidosis if administered in large volumes rapidly.

When using Glucose Com Cloreto De Sodio Basi, clinicians should observe specific precautions to minimize risks and ensure appropriate patient selection.

- Assess baseline serum electrolytes and glucose before administration. - Adjust infusion rate in patients with cardiac or renal impairment. - Avoid use in individuals with known hypersensitivity to sodium chloride or glucose. - Monitor fluid balance to prevent overload in susceptible patients. - Use compatible IV sets and avoid mixing with drugs that may precipitate. - Document infusion volume and rate in the patient’s medical record. - Consider alternative isotonic solutions if the patient requires specific electrolyte composition.

Glucose Com Cloreto De Sodio Basi may interact with other intravenous agents; awareness of compatible and incompatible combinations helps maintain solution stability and patient safety.

Avoid: - Do not mix with calcium-containing solutions, as precipitation of calcium chloride may occur. - Avoid concurrent infusion with high‑concentration dextrose solutions that could cause hyperosmolarity.

Use with caution: - Co‑administration with potassium chloride requires careful monitoring of serum potassium levels. - Concurrent use with diuretics may amplify electrolyte shifts; monitor electrolytes closely. - When combined with blood products, ensure compatible infusion rates to prevent hemolysis. - Use cautiously with insulin therapy, as glucose load may affect glycemic control.